Alignment Healthcare (NASDAQ:ALHC) Insider Hyong Kim Sells 18,404 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 18,404 shares of the business’s stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $17.84, for a total transaction of $328,327.36. Following the completion of the transaction, the insider owned 367,701 shares of the company’s stock, valued at $6,559,785.84. The trade was a 4.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Hyong Kim also recently made the following trade(s):

• On Tuesday, January 6th, Hyong Kim sold 16,506 shares of Alignment Healthcare stock. The shares were sold at an average price of $21.35, for a total transaction of $352,403.10.
• On Monday, December 29th, Hyong Kim sold 12,694 shares of Alignment Healthcare stock. The shares were sold at an average price of $18.74, for a total transaction of $237,885.56.

Alignment Healthcare Trading Down 0.2%

Shares of ALHC stock traded down $0.03 during trading hours on Thursday, reaching $18.16. The company’s stock had a trading volume of 3,987,587 shares, compared to its average volume of 3,191,394. The firm’s 50 day simple moving average is $20.57 and its 200-day simple moving average is $18.78. Alignment Healthcare, Inc. has a fifty-two week low of $11.63 and a fifty-two week high of $23.87. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.80.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.10. The company had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.Alignment Healthcare’s revenue was up 44.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.16) EPS. As a group, research analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Upgrades and Downgrades

ALHC has been the topic of several research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, January 21st. TD Cowen increased their price objective on shares of Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a research note on Friday, January 16th. Wall Street Zen lowered shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, March 7th. Piper Sandler boosted their target price on shares of Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 6th. Finally, KeyCorp reiterated an “overweight” rating and issued a $28.00 price target on shares of Alignment Healthcare in a research note on Thursday, January 22nd. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $24.56.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ALHC. Summit Securities Group LLC bought a new position in Alignment Healthcare in the 4th quarter valued at approximately $26,000. Parallel Advisors LLC boosted its position in Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after buying an additional 773 shares during the period. Larson Financial Group LLC bought a new stake in Alignment Healthcare during the 3rd quarter worth approximately $33,000. First Horizon Corp acquired a new position in Alignment Healthcare in the 4th quarter valued at approximately $39,000. Finally, SBI Securities Co. Ltd. increased its position in Alignment Healthcare by 4,868.9% in the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock valued at $42,000 after acquiring an additional 2,970 shares during the period. Institutional investors and hedge funds own 86.19% of the company’s stock.

Key Stories Impacting Alignment Healthcare

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Recent analyst upgrades/price-target raises provide near-term support (UBS raised target to $21, Piper Sandler to $30, JPMorgan to $26), and the consensus target remains above the current price—helping underpin valuation.
• Positive Sentiment: Solid quarterly results: February quarter beat EPS and revenue estimates (revenue +44% YoY; EPS beat by $0.10), showing growth momentum in Medicare Advantage enrollment and monetization that supports longer-term upside.
• Neutral Sentiment: Zacks ran a comparison piece weighing ALHC vs. BrightSpring (BTSG) for value investors — useful context but not a company-specific catalyst. BTSG or ALHC: Which Is the Better Value Stock Right Now?
• Neutral Sentiment: Reported short-interest data is effectively zero/NaN in the recent reports (likely a reporting quirk); it doesn’t indicate a build of short pressure currently.
• Negative Sentiment: Cluster of insider sales from senior executives — President Dawn Maroney sold 30,000 shares (~$524k at $17.48) and other officers (Andreas P. Wagner, Robert L. Scavo) sold sizable blocks (~11k–12k shares each). Heavy insider selling can signal liquidity needs or personal diversification and often weighs on sentiment. Maroney sale filing: Maroney Form 4
• Negative Sentiment: Additional insider filings: Andreas P. Wagner sales (Form 4) and Robert L. Scavo sale (Form 4) were also disclosed, adding to the headline of insider liquidation. Wagner filing: Wagner Form 4 · Scavo filing: Scavo Form 4
• Negative Sentiment: Independent sell-side views: Weiss Ratings reiterated a “sell (D-)” and Wall Street Zen trimmed its rating to a hold — these dissenting views add downside risk if they influence broader investor sentiment. Weiss Ratings · Wall Street Zen reference included in company coverage.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.